•  
  •  
  •  
  •  

2025-08-31 12:35:39

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism

Keywords Selected:  UnichemLaboratories

Stock Report

  • Unichem Laboratories Ltd receives EIR from USFDA classifying Roha API facility as VAI
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • Unichem Laboratories Ltd receives 4 observations from USFDA for Pithampur API facility
  • Unichem Laboratories Ltd gets 5 observations from USFDA for Goa formulation facility
  • Unichem Laboratories Ltd consolidated Q3 FY24 PAT rises to Rs. 83.99 crores
  • Unichem Laboratories Ltd receives ANDA approval for Doxazosin Tablets
  • Unichem Laboratories Ltd receives ANDA approval for Prasugrel Tablets
  • Unichem Laboratories Ltd Q1FY24 consolidated loss at Rs. 66.83 lakhs
  • Unichem Laboratories Ltd Q4 FY2023 consolidated loss at Rs. 44.26 crores
  • Ipca Laboratories Ltd to acquire majority stake in Unichem Laboratories Ltd
  • Unichem Laboratories Ltd appoints Ms. Priti Puri as additional independent director
  • Unichem Laboratories Ltd receives ANDA approval for Ranolazine Extended-Release Tablets
  • Unichem Laboratories Ltd consolidated Q3FY23 loss at Rs. 63.92 crores
  • Unichem Laboratories receives ANDA approval for Extended Phenytoin Sodium Capsules
  • Unichem Laboratories Ltd sells 1st tranche of stake in Optimus for Rs. 270.98 crores
  • ICRA downgrades Unichem Laboratories' rating for Rs. 176 crs bank facilities
  • Unichem Laboratories receives ANDA approval from USFDA for Carbamazepine Tablets USP
  • Unichem Laboratories receives ANDA Approval for Quetiapine Extended-Release Tablets
  • Unichem Laboratories receives ANDA approval for Labetalol Hydrochloride Tablets
  • Unichem Laboratories Ltd Q1 FY2023 consolidated loss at Rs. 23.36 crores
  • Unichem Laboratories Ltd reports surge in Q4FY22 consolidated PAT to Rs. 71.47 crores
  • Unichem Laboratories Ltd Board recommends Dividend of Rs. 4
  • Unichem Laboratories Limited to sell its stake in Optimus
  • Unichem Laboratories receives ANDA approval for Nebivolol Tablets

Latest Post

  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024